COMMERCIAL FEATURE
SKIN QUALITY REDEFINED
As skin quality becomes an increasingly prominent focus in aesthetic practice, Teoxane introduces babyGLOW™ and babyGLOW™ for HIM, two protocols designed to address skin revitalisation with a focus on precision and natural-looking results.1
For practitioners, the growing focus on skin quality reflects a broader shift in treatment planning: beyond individual lines or areas of concern, towards the overall appearance and condition of the skin. This places greater emphasis on subtle improvements that complement a patient’s existing features.
Meet Teoxane babyGLOW™ and babyGLOW™ for HIM.
Today’s patients are increasingly looking for treatments that deliver visible skin quality improvements while still looking unmistakably like themselves. babyGLOW™ by Teoxane is an injection protocol using Teosyal Redensity1 (3ml), creating a treatment experience designed around precision, comfort and visible skin revitalisation.1
Using eight validated injection points on each side of the face2 , Teoxane babyGLOW™ gives practitioners a reproducible framework that is simple to integrate into clinical practice.
At its core is Redensity1 , combining non-crosslinked hyaluronic acid with 10mg/g Concentrated Dermo Restructuring Complex(containing Zinc, Copper,
Antioxidants and Amino Acids Complex)*
Clinical evaluation has demonstrated changes after nine days3 including: +1400% GAGs | +98% Collagen IV | +26% Fibrillin-I
ADAPTING THE PROTOCOL FOR MALE PATIENTS
Teoxane babyGLOW™ is now reaching a new patient.
Teoxane babyGLOW™ for HIM adapts the treatment points to better reflect male anatomy and masculine aesthetic ideals4 , while retaining the speed, comfort and natural-looking results of the original protocol.1
The objective is subtle: fresher, more energised-looking skin without appearing noticeably treated.
For practitioners, the two protocols offer an opportunity to consider how skin quality treatments can be adapted to different patient groups, with injection approaches tailored to differing anatomical characteristics and aesthetic preferences.
Together, Teoxane babyGLOW™ and babyGLOW™ for HIM give clinics two distinct ways to introduce patients to the growing skin quality category, supported by Teoxane education, training and clinic activation tools.
One protocol philosophy. Two patient opportunities. babyGLOW™ by Teoxane.
REFERENCE BOX
1. Teoxane, Data on file collected from HCPs reports, Dec 16th 2025 - Redensity 1 and the babyGlow Protocol for Beautification and Rejuvenation
2. Caboni S, et al. Rationale & Description of a New Treatment Protocol for Skin Beautification and Rejuvenation using a Non-Crosslinked HA [Poster presentation].
3. Fanian F, et al. In vivo injection of oligonutrients and high molecular weight hyaluronic acid – results of a randomized controlled trial. Aesthetic Medicine. 2017; 3(4):23-34.
4. Vazirnia A, Braz A, Fabi SG. Nonsurgical jawline rejuvenation using injectable fillers. J Cosmet Dermatol. 2020 Aug;19(8):1940-1947.
*Specially designed for Teoxane, and diluted to 1/100 in the manufacture of our gels.